Regenerative Medicine Catalyst Grants 2025 - Novo Nordisk
Supports translational research in regenerative medicine to address key clinical challenges and advance therapies, emphasizing collaboration and clinical application in the Nordic region.
Funder: Novo Nordisk
Due Dates (Anticipated): September 2026
Funding Amounts: Up to DKK 5 million (standard projects) or DKK 10 million (collaborative projects) per grant; up to 3 years; total call budget DKK 100 million.
Summary: Supports translational research in regenerative medicine, advancing solutions to key challenges and promoting collaboration in the Nordic region and beyond.
Description
This program provides catalytic funding for translational research projects in regenerative medicine, targeting major challenges and accelerating the field toward clinical application. The grant is designed to strengthen the Nordic regenerative medicine ecosystem, foster international collaboration, and lower time and cost barriers to new therapies. Projects must address one or more of the following thematic areas:
- Challenges in autologous and allogeneic cell therapy
- Applications of stem cell-based disease modelling
- Engineering biomaterials for regenerative medicine therapy
- Transitioning cell therapies from academia to clinical development
Projects should demonstrate clear translational and applied focus, aiming to progress regenerative medicine discoveries toward clinical use, develop new protocols or methods, and articulate long-term impact.
